Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction
Danielle Sambo, Joseph J. Lebowitz, Habibeh Khoshbouei
Pharmacology & Therapeutics (2018) Vol. 186, pp. 152-167
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology
Richa Aishwarya, Chowdhury S. Abdullah, Mahboob Morshed, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 77
Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models
Lucie Crouzier, Alberto Danese, Yuko Yasui, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 631
Open Access | Times Cited: 49
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Sarah E. Davis, Abagail B. Cirincione, Ana Catya Jiménez-Torres, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15340-15340
Open Access | Times Cited: 25
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function
Chowdhury S. Abdullah, Richa Aishwarya, Shafiul Alam, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 51
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
Michael Colwell, Hosana Tagomori, Sarah Chapman, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development
Peng Ren, Jingya Wang, Nanxi Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
The sigma-1 receptor: a mechanistically-informed therapeutic target for antidepressants
Nan Xiao, Liyang Yin, Kayla M. Teopiz, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access
The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics
Jared VanderZwaag, Torin Halvorson, Kira Dolhan, et al.
Neurochemical Research (2022) Vol. 48, Iss. 4, pp. 1129-1166
Closed Access | Times Cited: 17
Novel therapeutics in development for the treatment of stimulant-use disorder
Erica J. Young, László Radnai, В. А. Приходько, et al.
Current Opinion in Neurobiology (2024) Vol. 87, pp. 102898-102898
Open Access | Times Cited: 3
Mechanisms and treatments of methamphetamine and HIV-1 co-induced neurotoxicity: a systematic review
Lin Miao, Haowei Wang, Yi Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Sex‐specific susceptibility to psychotic‐like states provoked by prenatal THC exposure: Reversal by pregnenolone
Roberto Frau, Miriam Melis
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 2
Open Access | Times Cited: 9
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
Sara Corsi, Simona Scheggi, Alessandra Pardu, et al.
Experimental Neurology (2023) Vol. 363, pp. 114370-114370
Open Access | Times Cited: 8
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review
Eleanor White, Tom Kennedy, Simon Ruffell, et al.
International Journal of Toxicology (2024) Vol. 43, Iss. 3, pp. 327-339
Open Access | Times Cited: 3
Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview
Genís Oña, Ingrid Reverte, Giordano Novak Rossi, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 12, pp. 1190-1200
Closed Access | Times Cited: 7
Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection
Mingmei Wang, Chunlei Wan, Tao He, et al.
Neuropharmacology (2020) Vol. 196, pp. 108360-108360
Closed Access | Times Cited: 20
Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats
Melinda Hersey, Maddalena Mereu, Claire S. Jones, et al.
European Journal of Neuroscience (2024) Vol. 59, Iss. 10, pp. 2436-2449
Closed Access | Times Cited: 2
Short-chain fatty acids mitigate Methamphetamine-induced hepatic injuries in a Sigma-1 receptor-dependent manner
Kai-Kai Zhang, Jian-Zheng Yang, Chang-Hao Cheng, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 280, pp. 116538-116538
Open Access | Times Cited: 2
G protein-coupled receptor heteromers are key players in substance use disorder
Lyes Derouiche, Dominique Massotte
Neuroscience & Biobehavioral Reviews (2018) Vol. 106, pp. 73-90
Open Access | Times Cited: 19
Antioxidant cascades confer neuroprotection in ethanol, morphine, and methamphetamine preconditioning
Shuang Lu, Lvshuang Liao, Bing Zhang, et al.
Neurochemistry International (2019) Vol. 131, pp. 104540-104540
Closed Access | Times Cited: 18
In vitroandin vivosigma 1 receptor imaging studies in different disease states
Hebaallah M. Agha, Christopher R. McCurdy
RSC Medicinal Chemistry (2020) Vol. 12, Iss. 2, pp. 154-177
Open Access | Times Cited: 18
The Role of Hyperthermia in Methamphetamine-Induced Depression-Like Behaviors: Protective Effects of Coral Calcium Hydride
Xintao Wang, Bonan Tong, Rongji Hui, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 14
Open Access | Times Cited: 11
MicroRNAs in Methamphetamine-Induced Neurotoxicity and Addiction
Deng Bi, Zhirui Zhang, Huixuan Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms
Zifen Xu, Yushuang Lei, Huan Qin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7572-7572
Open Access | Times Cited: 11
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway
Baoyu Shen, Dongxian Zhang, Xiaofeng Zeng, et al.
Psychopharmacology (2022) Vol. 239, Iss. 5, pp. 1521-1537
Closed Access | Times Cited: 10
Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters
Samane Jahanabadi, Shayan Amiri, Mehdi Karkeh-abadi, et al.
Fitoterapia (2023) Vol. 169, pp. 105620-105620
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top